Uncomplicated hypertension Circulatory System Essential (primary) hypertension
Conditions
Interventions
1. Control: basic integrated prescribing and medical record system
2. Experimental: control and comparative information on out-ot-pocket expenditures at time of prescribing
Sponsors
McGill University (Université McGill) (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Male or female subjects, 18 years of age or older 2. Make one or more visits to an enrolled study physician during follow-up 3. Have a diagnosis of uncomplicated hypertension (i.e. hypertension recorded by the study physician in the therapeutic indication field that must be completed with each prescription) 4. No documented diabetes, congestive heart failure, established atherosclerotic disease, peripheral arterial disease, ischaemic heart disease (angina or prior myocardial infarction), past cerebrovascular accident or transient ischaemic attack (TIA), renal disease, asthma, chronic obstructive pulmonary disease (COPD) or left ventricular hypertrophy
Exclusion criteria
Exclusion criteria: 1. Documented diabetes 2. Congestive heart failure 3. Established atherosclerotic disease 4. Peripheral arterial disease 5. Ischaemic heart disease (angina or prior myocardial infarction)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Monthly cost of prescription(s) for uncomplicated hypertension at last date of prescribed or dispensed anti-hypertensive medication in the 12-month follow up period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Primary and secondary adherence to anti-hypertensive medication during last six months of follow up. | — |
Countries
Canada
Outcome results
None listed